Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Non Operating Income (2010 - 2012)

Sangamo Therapeutics (SGMOQ) posted Non Operating Income of -$109000.0 for Q4 2012, down 1008.33% on a QoQ basis from $12000.0 in Q3 2012, and down 1916.67% year-over-year from $6000.0 in Q1 2012.

Analysis

Sangamo Therapeutics (SGMOQ) Non Operating Income (2010 - 2012) Analysis & Trends

Sangamo Therapeutics has reported Non Operating Income for 3 years, with the latest figure at -$109000.0 in Q4 2012.

  • On a quarterly basis, Non Operating Income fell 1916.67% year-over-year to -$109000.0 in Q4 2012; TTM through Dec 2012 was -$66000.0, a 192.96% decrease from a year earlier, with the FY2014 full-year figure at $364000.0, up 343.9% from the prior year.
  • Non Operating Income was -$109000.0 for Q4 2012 at Sangamo Therapeutics, down from $12000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $23000.0 in Q1 2011, with the low at -$109000.0 in Q4 2012.
  • Average Non Operating Income over 3 years is $4200.0, with a median of $16500.0 recorded in 2010.
  • The sharpest annual moves came in 2011 and 2012: Non Operating Income changed 0.0% in 2011, then plunged 1916.67% in 2012.
  • Over 3 years, Non Operating Income stood at $17000.0 in 2010, then plunged by 64.71% to $6000.0 in 2011, then slumped by 1916.67% to -$109000.0 in 2012.
  • The last three Non Operating Income figures came in at -$109000.0 (Q4 2012), $12000.0 (Q3 2012), and $16000.0 (Q2 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Krystal Biotech 10.09 Bn 9.24 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.22 Bn 5.22 Bn - 27.08 Mn
3 Iovance Biotherapeutics 3.90 Bn 3.60 Bn 55.72 Mn -
4 Legend Biotech 3.67 Bn 2.70 Bn 251.50 Mn -
5 uniQure 3.10 Bn 3.10 Bn 5.49 Mn -
6 Beam Therapeutics 2.69 Bn 2.69 Bn - 3.88 Mn
7 Precigen 2.43 Bn 2.43 Bn 52.17 Mn -2.57 Mn
8 Sarepta Therapeutics 2.35 Bn 1.55 Bn 251.87 Mn -15.04 Mn
9 Vericel 1.99 Bn 1.82 Bn 56.40 Mn 1.77 Mn
10 Sangamo Therapeutics 43.29 Mn 22.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -109,000.00
Sep 30, 2012 12,000.00
Jun 30, 2012 16,000.00
Mar 31, 2012 15,000.00
Dec 31, 2011 6,000.00
Sep 30, 2011 20,000.00
Jun 30, 2011 22,000.00
Mar 31, 2011 23,000.00
Dec 31, 2010 17,000.00
Sep 30, 2010 20,000.00